The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York October 29, 2024 Meeting of the Pharmacy Compounding Advisory Committee Rescheduling psilocybin and MDMA in Australia A process explainer The growing market for injectable peptides includes many schedule 4 drugs that are not yet approved for use in Australia but can be prescribed by a doctor ASCIA Guidelines Adrenaline (Epinephrine) Device Prescription Australasian Society of Clinical Immunology and Allergy (ASCIA)